EUVIMEDEUVIMED entdecken
Crossref

Development and Preclinical Evaluation of a Selinexor-Derived Radiotracer [ 68 Ga]Ga-NOTA-Selinexor for Imaging XPO1 Expression in Multiple Myeloma

Xinlin Zhong, Junjie Yan iD, Chen Su, Wei Xu, Xinyu Wang iD, Donghui Pan, Yuping Xu, Lizhen Wang, Chongyang Chen, Min Yang iD

Molecular Pharmaceutics · 04.05.2026 · 23 (5) · 2984-2996

DOI: 10.1021/acs.molpharmaceut.5c01792 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 02.04.2026. Verfasst von Xinlin Zhong und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences and Health Engineering, Jiangnan University, Wuxi 214122, P. R. China. Hauptthemen laut MEDLINE: Triazoles, Multiple Myeloma, Hydrazines, Karyopherins. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Basic Research Program of Jiangsu Province, National Natural Science Foundation of China, Project of Jiangsu Provincial Health and Wellness Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TriazolesMultiple MyelomaHydrazinesKaryopherinsReceptors, Cytoplasmic and NuclearGallium RadioisotopesRadiopharmaceuticalsAnimalsHumansMiceExportin 1 ProteinCell Line, TumorPositron-Emission TomographyFemaleTissue DistributionHeterocyclic Compounds, 1-RingXenograft Model Antitumor Assays

Stichwörter der Autor:innen

NOTA-selinexorexportin 1gallium-68multiple myelomapositron emission tomography (PET) imaging

Substanzen

TriazolesHydrazinesKaryopherinsselinexorReceptors, Cytoplasmic and NuclearExportin 1 ProteinGallium RadioisotopesRadiopharmaceuticalsGallium-68Heterocyclic Compounds, 1-Ring

Autor:innen und Institutionen

  • School of Life Sciences and Health Engineering, Jiangnan University, Wuxi 214122, P. R. China.
  • NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, P. R. China.
  • School of Chemical and Material Engineering, Jiangnan University, Wuxi 214122, P. R. China.
  • Affiliated Women's Hospital of Jiangnan University, Jiangnan University, Wuxi 214002, P. R. China.

ORCID-Profile: Junjie Yan, Xinyu Wang, Min Yang

Förderung

  • Basic Research Program of Jiangsu Province
  • National Natural Science Foundation of China
  • Project of Jiangsu Provincial Health and Wellness Commission
  • Jiangsu Provincial Medical Key Laboratory

Zitieren

APA

Zhong, X., Yan, J., Su, C., Xu, W., Wang, X., Pan, D., Xu, Y., Wang, L., Chen, C., & Yang, M. (2026). Development and Preclinical Evaluation of a Selinexor-Derived Radiotracer [ 68 Ga]Ga-NOTA-Selinexor for Imaging XPO1 Expression in Multiple Myeloma. Molecular Pharmaceutics, 23(5), 2984-2996. https://doi.org/10.1021/acs.molpharmaceut.5c01792

Vancouver

Zhong X, Yan J, Su C, Xu W, Wang X, Pan D, et al. Development and Preclinical Evaluation of a Selinexor-Derived Radiotracer [ 68 Ga]Ga-NOTA-Selinexor for Imaging XPO1 Expression in Multiple Myeloma. Molecular Pharmaceutics. 2026;23(5):2984-2996. doi:10.1021/acs.molpharmaceut.5c01792

BibTeX
@article{Zhong2026,
  author = {Zhong, Xinlin and Yan, Junjie and Su, Chen and Xu, Wei and Wang, Xinyu and Pan, Donghui and Xu, Yuping and Wang, Lizhen and Chen, Chongyang and Yang, Min},
  title = {Development and Preclinical Evaluation of a Selinexor-Derived Radiotracer [ 68 Ga]Ga-NOTA-Selinexor for Imaging XPO1 Expression in Multiple Myeloma},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  volume = {23},
  number = {5},
  pages = {2984--2996},
  doi = {10.1021/acs.molpharmaceut.5c01792}
}
Kostenlos starten →